Navigation Links
Pharmaceutical Launch Excellence Services Delivers Market Entry Road Map
Date:3/4/2011

CHAPEL HILL, N.C., March 4, 2011 /PRNewswire/ -- The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs.

Facing an ever-changing launch landscape, product launch leaders are looking to guard against uncertainty as they guide new therapies through the labyrinth of regulatory and marketplace challenges.

To that end, Best Practices, LLC has collected hundreds of best practices, narratives, and metrics around the issue of new product launch. To provide launch executives with the critical information they need to succeed with a product launch, we have consolidated our best launch research and services into the Pharmaceutical Launch Excellence Services.

The Launch Excellence Services product connects launch professionals to benchmarking and networking solutions to address a variety of mission-critical issues, including:

  • Spend across launch activities
  • Differentiating a new product from competitors
  • Portfolio decisions
  • Timing and value of different new product planning activities
  • Coordinating Regional and Global launch activities
  • Strength and weakness of various structural approaches for new product planning
  • Balancing development and commercial interests
  • Brand team responsibilities
  • Use of public relations to support launch

Pharmaceutical executives will find the primary and secondary research information provided in this product essential for identifying trends, gaining a better understanding of the market and ensuring a strong market entry for new products.

To explore the Pharmaceutical Launch Excellence Services in greater detail, download our complimentary research excerpt at http://www3.best-in-class.com/or2.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For more than 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.  For more information about the company, go to www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
2. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
3. Endo Pharmaceuticals Launches FORTESTA™ (Testosterone) Gel for Topical Use Class III for Adult Men in the U.S. With Low Testosterone
4. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
5. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
6. Onyx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
7. Savient Pharmaceuticals to Present at the 31st Annual Cowen & Co. Health Care Conference
8. Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.
9. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
10. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
11. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... 16, 2017 Transparency Market Research states ... Devices Market  held a huge share of 43% in 2015. ... frontrunners in the overall market, grabbing the undivided attention of ... across geographies, and strong product portfolio is expected to keep ... ...
(Date:1/16/2017)... , Jan. 16, 2017  Dovetail Genomics today announced ... and assembly service, which yields chromosome-scale genome assemblies. The ... a Dovetail-hosted workshop on Jan. 17 at the Plant ... San Diego . "We are thrilled ... launch of our Dovetail Hi-C offering," said Todd ...
(Date:1/16/2017)... 2017  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is pleased ... , CFA to its Board of Directors. He is ... Asset Management LLC . He is also the Chief ... investment advisory firm with over $1.5 billion under management. ... in security analysis and portfolio management. He began his ...
Breaking Medicine Technology:
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... ... the availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit ... audit protocols to understand the scope of their EHS regulatory obligations and rapidly ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... to provide first-quality education and high-level training standards to an international multidisciplinary group ... eating disorder problems. As a way to further its mission at the grassroots ...
(Date:1/15/2017)... NY (PRWEB) , ... January 15, 2017 , ... In ... accounts in the United States for the asthma & allergy friendly mark. This certification ... to independently test and identify consumer products to be more suitable for the 60+ ...
(Date:1/15/2017)... ... January 15, 2017 , ... ... best physicians in eight Bay Area counties for 2017. Almost 1,000 nominations were ... company managing the award process. Results were announced the magazine’s January 2017 ...
(Date:1/14/2017)... ... January 13, 2017 , ... According to ... magnesium-rich Mediterranean diet may lower the risk of type 2 diabetes, Alzheimer’s, and ... many health and wellness benefits linked to a Mediterranean diet are only some ...
Breaking Medicine News(10 mins):